University of Vermont

College of Medicine

Department of Pharmacology

This page has moved to here!


Researching Small Vessel Disease with the Fondation Leducq

Fondation Leducq logo

The Leducq Center Against Small Vessel Disease has a goal of understanding cerebral blood flow. The research funded by the Fondation Leducq Transatlantic Network for Excellence is co-lead by North American Coordinator Dr. Mark T. Nelson, University Distinguished Professor and Chair of the Department of Pharmacology at the University of Vermont, and Dr. Anne Joutel, Research Director - INSERM at the University of Paris, 7-Denis Diderot.

Leducq Small Vessel Disease Network

Understanding cerebrovascular function and dysfunction presents a daunting challenge to both clinicians and basic scientists. Until now, a research network on SVD has not bee possible owing to a lack of appropriate mouse models, difficulties in adapting molecular and imaging techniquest to the mouse brain microcirculation, and the absence of a critical mass of scientific information and expertise. The convergence of emerging technologies and growing insight into cerebral SVD processes - made possible in large part by the research efforts of members of the Network- create a moment in time ripe for a comprehensive and productive exploration of monogenetic (CADASIL/CARDASIL) and common forms of SVD.

The Leducq Center Against Small Vessel Disease (LCASVD) encourages collaborative and interactive scientific investigation into causes of — and solutions for — Small Vessel Disease and related conditions.

Last modified June 10 2016 09:05 AM